28th Annual Diabetes Update
28th Annual Diabetes Update
| Release Date | January 24, 2024 |
| Expiration Date | April 10, 2024 |
| CME | 4.75 credits |
28th Annual Diabetes Update
Saturday, March 9, 2024; 8:00am - 2:00pm (registration opens at 7:15am)
Registration Deadline: March 1, 2024 - NO LATE registrations will be accepted!
Location: John H. Ammon Education Center, ChristianaCare Newark Campus
(limited number of virtual spots available)
Event Questions: For ALL event questions, including virtual event link, sound, visuals and/or recordings, please contact Amy Minsker at the ChristianaCare CME office at amy.l.minsker@christianacare.org
$95 In-Person Attendance
$85 Limited Virtual Space
$0 Residents and Fellows
Students - please contact Amy Minsker for registration amy.l.minsker@christianacare.org
ChristianaCare Employees Only: Cost Center payments are accepted (an email will be sent to those paying via cost center after registration has closed).Check payments can be made payable to:
ChristianaCare (please note the conference in the memo section).
Checks must be received at least 2 weeks prior to the conference, or your registration will be canceled.
Please send all checks to:
ChristianaCare-Amy Minsker Office of Continuing Medical Education
4755 Ogletown-Stanton Road, Newark, DE 19718, Office 2E64A
Overview
This educational opportunity is designed to provide an update on diabetes and diabetes related co-morbidities, reinforcing the importance of early diagnosis, recent advances in treatment and to meet identified needs of diabetes clinicians in this area. This year’s faculty will present on an array of topics: the importance of weight management with surgical and medical treatment options, updates in standards of care, and caring for the pediatric population with diabetes.
Target Audience
This activity is intended for all physicians from all specialties, pharmacists,physician assistants, nurses, and nurse practitioners, as well as residents, and medical students. Diabetes affects all providers of medical care. The specific method of employing the information that is learned will be dependent upon each individual's role.
Statement of Need
TCFRD is considered a pediatric disorder. Patients are living longer. PCPs need to understand CFRD with it's unique pathophysiology.
GLP-1 RAs are widely used for diabetes and obesity. They provide benefits on other organ systems. This is not widely known or understood.
SDB, such as sleep apnea, is very common in people with diabetes. The disorder can be challenging to diagnose and manage. The benefit of treatment on glucose control is not well known.
Educational Objectives
Upon completion of this activity learners should be able to:
- Discuss cystic fibrosis related diabetes (CFRD).
- Discuss the diabetes drugs called GLP-1 RAs will be examined for effects beyond glucose lowering.
- Discuss the effects of sleep disordered breathing (SDB) on diabetes will be reviewed.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of Delaware and Christiana Care. The Medical Society of Delaware is accredited by the ACCME to provide continuing medical education for physicians.
It is the policy of the Medical Society of Delaware (MSD) to comply with the ACCME Standards for Commercial Support of Continuing Medical Education (CME). In keeping with these standards, all faculty participating in continuing medical education provided by MSD are expected to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations.
Joint providership of CME by MSD in no way implies endorsement of any product or service.
This activity is not supported by commercial funding.
Credit Designation Statement
The Medical Society of Delaware designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity session enables the participant to earn up to 4.75 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Upon successful completion of this course, the Medical Society of Delaware (MSD) will submit your completion data to ABIM via ACCME’s Program and Activity Reporting System (PARS) for MOC points.
Faculty and Disclosures
In accordance with the appropriate accrediting bodies, all planners, teachers, and authors with control over activity content are required to disclose to the provider any relevant financial relationships (those held by the planner or significant other, currently or within the last 24 months) with commercial interests/ineligible companies. Accredited providers are required to provide this information to learners before the start of an activity.
The following is a list of the faculty, along with any information they have disclosed regarding their relevant financial relationships.
James Lenhard, MD (Planner, Activity Director, Moderator) - has no relevant financial relationship(s) with ineligible companies to disclose
Amy Minsker (Planner, Coordinator) - has no relevant financial relationship(s) with ineligible companies to disclose
Amy B. Wachter, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Barbara A. Willey, RN, MSN (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Dorothy Hyatt, RN, MSN, CDCES (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Julie Garey RD, LDN, CDE (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Omar Khan, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Prakash Seshadri, MD (Planner) - has no relevant financial relationship(s) with ineligible companies to disclose
Tal Grunwald, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Sirimon Reutrakul, MD, CDCES (Speaker) - received speaker fee from Eli Lilly - all of the relevant financial relationships listed for this individual have been mitigated.
Shivani Vekaria, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Alyson K. Myers, MD (Speaker) - has no relevant financial relationship(s) with ineligible companies to disclose
Stephanie O'Connor (Panel Moderator) - has no relevant financial relationship(s) with ineligible companies to disclose
Disclaimer
All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this educational event. No single reference or service can take the place of medical training, education and experience. This educational event does not define a standard of care, nor is it intended to dictate an exclusive course of management. This information should not substitute for a visit or consultation with a health care provider.
Technical Requirements
This activity is best experienced using the most current browser of Firefox, Chrome, Safari, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.
Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.